Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.84
Delayed Data
As of Feb 05
 -0.05 / -2.65%
Today’s Change
1.39
Today|||52-Week Range
9.37
+6.98%
Year-to-Date

Today’s Trading

Previous close1.89
Today’s open1.88
Day’s range1.82 - 1.92
Volume1,148,493
Average volume (3 months)2,896,435
Market cap$267.6M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)-59.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1,519.63%
P/E ratioNM
Price/Sales12.91
Price/Book10.17

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc-0.32-3.31%
VTLVital Therapies Inc-0.05-0.54%
NHTCNatural Health Trend...-0.07-0.33%
OMEDOncoMed Pharmaceutic...-0.20-2.10%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 9, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$55.5M
Annual profit (last year)-$37.5M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Narachi
Chief Commercial Officer &
Executive VP
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers